CIP2A Is a Predictor of Poor Prognosis in Colon Cancer

Prognostic role of CIP2A expression in serous ovarian cancer

(2011) C Böckelman et al.   BRITISH JOURNAL OF CANCER

State Disparities in Colorectal Cancer Mortality Patterns in the United States

(2011) D. Naishadham et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Increase in CIP2A expression is associated with doxorubicin resistance

(2011) Yeon A. Choi et al.   FEBS LETTERS

Single-Cell Multiplex Gene Detection and Sequencing with Microfluidically Generated Agarose Emulsions

(2010) Richard Novak et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis

(2010) Qian-Ze Dong et al.   ANNALS OF SURGICAL ONCOLOGY

Mechanisms of MYC stabilization in human malignancies

(2010) Melissa R. Junttila et al.   CELL CYCLE

A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity

(2010) F. Montagnani et al.   Colorectal Disease

CIP2A expression is increased in prostate cancer

(2010) Markku H Vaarala et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

KIAA1524: A novel MLL translocation partner in acute myeloid leukemia

(2010) Eva A. Coenen et al.   LEUKEMIA RESEARCH

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

(2010) K-F Chen et al.   ONCOGENE

CIP2A Is Associated with Human Breast Cancer Aggressivity

(2009) C. Come et al.   CLINICAL CANCER RESEARCH

Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways

(2009) D. Zhao et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

(2009) Salvatore Siena et al.   JNCI-Journal of the National Cancer Institute

MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer

(2009) Anchit Khanna et al.   JNCI-Journal of the National Cancer Institute

CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells

(2008) W. Li et al.   CLINICAL CANCER RESEARCH

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY